Literature DB >> 19493266

Should all patients receive single chemotherapeutic agent instillation after bladder tumour resection?

Jakub Dobruch1, Harry Herr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19493266     DOI： 10.1111/j.1464-410X.2009.08654.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  8 in total

Review 1.  Defining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancer.

Authors:  Ashish M Kamat; J Alfred Witjes; Maurizio Brausi; Mark Soloway; Donald Lamm; Raj Persad; Roger Buckley; Andreas Böhle; Marc Colombel; Joan Palou
Journal:  J Urol       Date:  2014-03-25       Impact factor: 7.450

2.  Overexpression of REIC/Dkk-3 suppresses the expression of CD147 and inhibits the proliferation of human bladder cancer cells.

Authors:  Yuhei Horikawa; Masami Watanabe; Takuya Sadahira; Yuichi Ariyoshi; Yasuyuki Kobayashi; Motoo Araki; Koichiro Wada; Kazuhiko Ochiai; Shun-Ai Li; Yasutomo Nasu
Journal:  Oncol Lett       Date:  2017-07-08       Impact factor: 2.967

3.  The use of immediate postoperative instillations of intravesical chemotherapy after TURBT of NMIBC among European countries.

Authors:  Juan Palou-Redorta; Morgan Rouprêt; Jack R Gallagher; Kylee Heap; Catherine Corbell; Brent Schwartz
Journal:  World J Urol       Date:  2013-08-02       Impact factor: 4.226

4.  Compliance with guidelines for patients with bladder cancer: variation in the delivery of care.

Authors:  Karim Chamie; Christopher S Saigal; Julie Lai; Jan M Hanley; Claude M Setodji; Badrinath R Konety; Mark S Litwin
Journal:  Cancer       Date:  2011-07-11       Impact factor: 6.860

5.  Significance of uracil/tegafur for preventing intravesical recurrence of non-muscle invasive urothelial carcinoma of the bladder.

Authors:  Ken-Ichi Harada; Hideaki Miyake; Tomoaki Terakawa; Masato Fujisawa
Journal:  Curr Urol       Date:  2012-04-30

Review 6.  [Intravesical therapy in non-muscle-invasive bladder cancer: indications and practical considerations].

Authors:  J Simon; F Finter; T Schnöller; R Hautmann; L Rinnab
Journal:  Urologe A       Date:  2009-11       Impact factor: 0.639

7.  Circulating proteomic signature for detection of biomarkers in bladder cancer patients.

Authors:  Taoufik Nedjadi; Hicham Benabdelkamal; Nada Albarakati; Afshan Masood; Ahmed Al-Sayyad; Assim A Alfadda; Ibrahim O Alanazi; Adel Al-Ammari; Jaudah Al-Maghrabi
Journal:  Sci Rep       Date:  2020-07-03       Impact factor: 4.379

8.  Clinical Practice Pattern of Immediate Intravesical Chemotherapy following Transurethral Resection of a Bladder Tumor in Korea: National Health Insurance Database Study.

Authors:  Gi Hyeon Seo; Jae Heon Kim; Ja Hyeon Ku
Journal:  Sci Rep       Date:  2016-03-15       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.